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A new 84/82 kDa calmodulin-binding protein, which also interacts with actin filaments, tubulin and spec- 
trin, was purified from the bovine synaptosomal membrane. The binding of calmodulin to this protein was 
Ca2+-dependent, and was inhibited by trifluoperazine, the association constant being calculated to be 
2.2 x lo6 Mm’. Maximally, 1 mol of calmodulin bound to 1 mol of the purified protein. This protein was 
phosphorylated by both kinase II (Caz+- and calmodulin-dependent kinase) and cyclic AMP-dependent ki- 
nase. In addition. antibody against this protein was demonstrated to have an immunological crossreactivity 
with synapsin I in the synaptosomal membrane. 
Calmodulin-binding protein; Synapsin I; Actin filament; Tubulin; Spectrin; Ca 2+ dependence; Calmodulin dependence; 
Kinase II 
1. INTRODUCTION 
Calmodulin is one of the ubiquitous intracellular 
Ca’+-mediators in many biological processes. It is 
now generally accepted that calmodulin activates 
several intracellular enzymes in a Ca2’-dependent 
manner (reviews [ 1,2]). In contrast, we purified or 
identified ten species of calmodulin-binding pro- 
teins which were devoid of enzyme activities. These 
proteins were shown to interact with cytoskeletal 
elements (actin filaments, tubulin, spectrin and 
calspectin) and to regulate their functions ([4], 
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review [3]). Since the synapse is a well-developed 
and highly specialized cytoarchitecture composed 
of cytoskeletal elements, it is a promising material 
to survey for cytoskeletal elements and targets of 
calmodulin which are involved in the regulation of 
cytoskeletal function. Actually, we have purified 
calspectin [5,6] and cytosynalin [7] from the brain 
synaptosomal membrane. In this paper, we 
demonstrate the purification of a new calmodulin- 
binding protein which also interacts with actin 
filaments, tubulin and spectrin. We then discuss 
the identification of this protein with synapsin I or 
erythrocyte protein 4.1. 
2. MATERIALS AND METHODS 
2.1. Materials 
Calmodulin was coupled to cyanogen-activated 
Sepharose 4B by the method of Klee and Krinks 
[8]. Microtubules were purified from bovine brain 
[9]. Spectrin [lo] and protein 4.1 [ 1 l] were purified 
from human erythrocytes. Kinase II purified from 
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rat brain was a generous gift from Drs H. Fujisawa 
and T. Yamauchi [12]. The catalytic subunit of 
cyclic AMP-dependent kinase was purchased from 
Sigma. The Triton X-100 treated synaptosomal 
membrane was prepared from bovine cerebral cor- 
tices [ 131. F-Actin was prepared from rabbit 
skeletal muscle as described in [14]. Iodination of 
a calmodulin-binding protein using “‘1 was 
prepared by the lactoperoxidase method [15]. The 
production of antibody against the purified 
calmodulin-binding protein and the preparation of 
the IgG fraction were carried out according to the 
method described elsewhere [7]. 
2.2. Analytical methods 
The detection of the 12’I-labeled 84/82 kDa pro- 
tein binding to cytoskeletal elements was carried 
out by the overlay method [7]. The interaction of 
the purified protein with F-actin was determined 
by the cosedimentation method [14]. The assay 
conditions for phosphorylation of the purified 
proteins or rat synaptosomal membrane are 
described in the corresponding legends. SDS- 
PAGE using 9% acrylamide was carried out in the 
buffer system of Laemmli [16]. Protein concentra- 
tions were determined by the method of Lowry et 
al. [17]. 
3. RESULTS AND DISCUSSION 
The Triton-treated synaptosomal membrane 
starting with 600 g of bovine cerebral cortices was 
dispersed with 250 ml of an extraction buffer 
(0.8 M KCl, 5 mM Mes, pH 7.2, 0.1 mM EGTA, 
0.1 mM dithiothreitol (DTT), 0.25 mM phenyl- 
methylsulfonyl fluoride, 0.1 mM diisopropyl flu- 
orophosphate, 1 pg/ml of leupeptin and 1 ,ug/ml 
of pepstatin A). After incubation at 37°C for 
30 min, the suspension was centrifuged at 105000 
x g for 60 min. The clear supernatant (fig.lA, 
lane b) was made 1 M KC1 and 5 mM MgCL by the 
addition of solid KC1 and 2 M MgC12, and applied 
to a hydroxyapatite column (3 x 3 cm) 
equilibrated with 1 M KCl, 5 mM Mes, pH 7.2, 
5 mM MgC12, 0.1 mM EGTA and 0.1 mM DTT. 
The flow-through fractions were collected (fig. 1 A, 
lane c), and exhaustively dialyzed against buffer A 
(5 mM Mes, pH 7.2, 0.1 mM EGTA and 0.1 mM 
DTT) plus 20 mM KCl. After dialysis, the sample 
was applied to a phosphocellulose column (1.2 x 
Fig.1. (A) SDS-PAGE of the purification procedures. 
Lanes: a, Triton-treated synaptosomal membrane; b, 
high salt extract; c, flow-through fraction of the 
hydroxyapatite column chromatography; d, after the 
phosphocellulose column chromatography. (B) Purifica- 
tion of the 84/82 kDa protein by the calmodulin-affinity 
chromatography. (1) Washing with buffer A plus 
0.3 mM CaClz and 500 mM KCl; (2) elution with buffer 
A plus 1 mM EGTA and 500 mM KCl. (Inset) SDS- 
PAGE of the purified protein (fraction no.47). 
2 cm) equilibrated with buffer A plus 20 rnM KCI. 
Then, the column was developed with a linear gra- 
dient of 20-600 mM KC1 in buffer A. The frac- 
tions corresponding to 400 mM ‘KC1 were collected 
(fig.lA, lane d), and dialyzed against buffer A plus 
100 mM KCl. The dialyzed sample was adjusted to 
0.2 mM CaClz by the addition of 100 mM CaC12 
and applied to a calmodulin-coupled Sepharose 4B 
column (fig.lB). Finally, the protein retained on 
the column was eluted with buffer A plus 1 mM 
EGTA and 500 mM KCl. The purified protein was 
composed of the doublet with molecular masses of 
84 and 82 kDa determined by SDS-PAGE (inset of 
fig.lB). The molar ratio of 84 and 82 kDa 
polypeptides in seven different preparations was 
0.45-0.55: 1. Ultimately, 1-2 mg of this protein 
was obtained from 600 g of bovine cerebral 
cortices. 
We confirmed the interaction of the 84/82 kDa 
protein with calmodulin using the zero-length 
crosslinker (1-ethyl-3-[3-(dimethylamino)propyl]- 
carbodiimide, EDC) [18]. The analysis of the 
crosslinked products on SDS gels revealed that the 
complex of 1251-labeled calmodulin with the 
84/82 kDa protein is formed only in the presence 
of Ca2+, but not in the absence of Ca2+ or in the 
presence of both Ca2+ and trifluoperazine (not 
shown). Based on Scatchard plot analysis (fig.2), 
the association constant of calmodulin to synapsin 
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Fig.2. Scatchard plot analysis for the calmodulin 
binding to the 84/82 kDa protein. Assay conditions were 
as follows: 20 mM imidazole.HCl, pH 7.2, 100 mM 
KCl, 0.1 mM DTT, 2 mM MgC12, 0.2 mM CaC12, 
75 pg/ml of the 84/82 kDa protein and various 
concentrations of 3H-labeled calmodulin (7-l 15 pg/ml). 
The binding assays were carried out according to our 
method [ 191. 
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Fig.3. Binding of the 12SI-labeled 84/82 kDa protein to 
cytoskeletal elements. The proteins separated by SDS gel 
were electrophoretically transferred to nitrocellulose 
membrane. The ‘251-labeled 84/82 kDa protein binding 
was determined by the overlay method. The ‘251-labeled 
84/82 kDa protein bound to the transblotted 
cytoskeletal proteins was detected by autoradiography. 
(A) Coomassie brilliant blue-stained SDS gels; (B) 
autoradiograms of the r2’I-labeled 84/82 kDa protein 
binding. Lanes: 1, spectrin; 2, microtubules; 3, actin. 
I was calculated to be 2.2 x lo6 M-’ by the alkali 
PAGE binding assay using 3H-labeled calmodulin 
as a ligand [19]. Maximally, 1 mol of calmodulin 
bound to 1 mol of synapsin I (not shown). The 
84182 kDa protein binding to cytoskeletal 
elements was also investigated. The 1251-labeled 
84182 kDa protein was bound to transblotted spec- 
trin, tubulin and actin, respectively (fig.3). 
However, an excess amount of calmodulin had no 
effect on these bindings regardless of the Ca2+ con- 
centrations (not shown). In our preliminary experi- 
ment, the 84/82 kDa protein possessed the binding 
ability with brain calspectin determined by the 
overlay method. Furthermore, we investigated the 
84/82 kDa protein-actin filament interaction by 
the cosedimentation method. The 84/82 kDa pro- 
tein bound to F-actin in a dose-dependent manner, 
and 1 mol of the 84182 kDa protein maximally 
bound to 7 mol of actin monomer (fig.4). Ca2+ 
and/or calmodulin had no effect on the bindings. 
By low-shear viscometry and electron microscopy, 
the 84/82 kDa protein did not show the crosslink- 
ing activity of actin filaments. 
Considering the similarity with regard to the 
localization in the synaptosomal membrane, 
molecular masses of the doublet and binding 
abilities to spectrin and tubulin, we made an at- 
tempt to identify the purified doublet as synapsin 
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Fig.4. Binding of the 84/82 kDa protein to F-actin. 
Assay conditions were as follows: 0.11 mg/ml of F- 
actin, 20 mM imidazole.HCl, pH 7.2, 100 mM KCl, 
2 mM MgClz, 0.1 mM DTT and indicated amounts of 
the 84/82 kDa protein in the presence of 1 mM EGTA 
(o), 0.2 mM CaClz (0), or 0.2 mM CaC12/40 gg per ml 
of calmodulin (A). After incubation at 30°C for 30 min, 
the reaction mixtures were centrifuged at 150000 x g for 
30 min. The precipitated fractions were subjected to 
SDS-PAGE. The amount of the 84/82 PDa protein 
bound to F-actin was quantified by densitometric 
scanning of SDS gel. 
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I by biochemical and immunological methods. 
Greengard and his associates [20,21 J first reported 
that synapsin I is one of the major substrates for 
kinase II and cyclic UP-dependent kinase in the 
synaptosomal membrane. In agreement with their 
Fig.5. Identification of the 84/82 kDa protein as 
synapsin I. The rat synaptosomal membrane prepared 
according to the method of Schulrnan and Greengard 
1211 was endogenously phosphorylated. Buffer 
conditions were the same as described in table 1. Protein 
concentration used were as follows: the rat 
synaptosomal membrane (0.5 mg/ml) and calmodulin 
(40pg/ml). After incubation at 30°C for 1 min, the 
synaptosomai membrane proteins were separated by 
SDS gel and the phosphoproteins were detected by 
autoradiography. The immunoprecipitation with anti- 
84/82 kDa protein antibody was carried out [25] using 
the phosphorylated synaptosomal membrane proteins 
under the same assay conditions in the presence of Ca2* 
and calmodulin (corresponding to lane c). The 
immunoprecipitated phosphoproteins were detected by 
autoradiography (lane d). 
observation, synapsin I (Ia and Ib) in the synap- 
tosomal membrane was phosphorylated by the en- 
dogenous kinase in a Ca2+- and calmodulin- 
dependent manner (fig.5, lanes a-c). Phosphor- 
ylated synapsin I (Xa and Ib) in the synaptosomal 
Table 1 
Phosphorylation of the 84/82 kDa protein and protein 4.1 by kinase II and catalytic 
subunit of cyclic AMP-dependent kinase 
Kinase Substrate Assay condition 32P incorporation 
(mol/mol) 
Ca2+ Calmodulin 
Kinase II 84/82 kDa protein - - 0.03 + 0.004 
-I” - 0.04 + 0.003 
+ + 3.29 f 0.13 
protein 4.1 - - 0.00 
+ - 0.01 f 0.002 
+ + 0.02 + 0.06 
Cyclic AMP- 84/82 kDa protein - - 1.28 + 0.06 
dependent kinase 
protein 4.1 - - 1.18 f 0.04 
The incubation medium was as follows: 5 mM Mes, pH 7.2, 10 mM MgCla, 1 mM 
DTT, 60 mM KCI, 0.1 mM [y-32PfATP (1 Ci/mmoI) and 0.2 mM CaC12 or 1 mM 
EGTA. Protein con~ntrations used were: 84/82 kDa protein (90 pglml), protein 4.1 
(90 pg/ml), kinase II (2 @g/ml), calmodulin (1 pg/ml) and catalytic subunit of cyclic 
AMP-dependent kinase (5 fig/ml). After incubation for 30 min at 37”C, the reaction 
was terminated by addition of SDS stop solution [26]. The proteins in the mixture were 
separated by SDS-PAGE and stained with Coomassie brilliant blue. The gel area 
corresponding to the 84/82 kDa protein or protein 4.1 was cut out, and counted for 
radioactive phosphate on a liquid scintillation spectrometer 
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membrane (lane c) was specifically immunopre- 
cipitated with anti-84/82 kDa protein antibody 
(fig.5, lane d). The purified protein reported here 
was also demonstrated to be a good substrate for 
both kinases. Maximally, 3.3 and 1.3 mol of 
phosphate were incorporated into 1 mol of this 
protein by kinase II and cyclic AMP-dependent 
kinase, respectively (table 1). Based on these 
results, we have clearly demonstrated that a new 
calmodulin-binding protein purified from the 
synaptosomal membrane which interacts with a 
broad range of cytoskeletal elements is synapsin I 
itself. Baines and Bennett [22] have recently 
reported that synapsin I is a protein immunologi- 
cally related to erythrocyte protein 4.1. However, 
protein 4.1 could be phosphorylated by cyclic 
AMP-dependent kinase, but not kinase II (table 1) 
and anti-synapsin I antibody showed no crossreac- 
tivity with protein 4.1 and vice versa [4]. Although 
protein 4.1 enhanced the spectrin (or calspectin)- 
actin filament interaction, synapsin I did not show 
this activity {4]. These results suggest he idea that 
synapsin I might be functionally and immuno- 
logically different from protein 4.1. 
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Baines and Bennett [22,23] have recently 
demonstrated that synapsin I is a spectrin-binding 
and microtubule-bundling protein, and Huttner et 
al. [24] have reported that phosphorylation of 
synapsin I by kinase II appeared to induce the 
dissociation of synapsin I from synaptic vesicles. 
In this paper, we have demonstrated that synapsin 
I also interacts with calmodulin and actin 
filaments. These observations lead to the con- 
sideration that synapsin I may play some role in 
the neurotransmitter release mediated by the 
synaptic vesicle-cytoskeleton i teraction. 
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